Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Molecular, clinical, and therapeutic determinants of outcome in NPM1 -mutated AML

Blood (2024) 144 (7): 714–728.

https://doi.org/10.1182/blood.2024024310

Published: 2024

Includes: Supplemental data

Journal Articles

Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission

Blood (2024) 143 (19): 1931–1936.

https://doi.org/10.1182/blood.2023023096

Published: 2024

Includes: Supplemental data

Journal Articles

Patient-Tailored Measurable Residual Disease Monitoring in Peripheral Blood Using Deep Sequencing and Droplet Digital PCR for Early Detection of Relapse in Childhood Acute Myeloid Leukemia: A NOPHO-DBH Collaborative Study

Anne-Sofie Skou, Kristian Løvvik Juul-Dam, Erik Delsing Malmberg, Anna Rehammar, Anastasia Soboli, Azadeh Anbarlou, Erik Kristiansson, Jonas Abrahamsson, Bernward Zeller, Kirsi Jahnukainen, Edwin Sonneveld, Birgitte Lausen, Anni Aggerholm, Hans Beier Ommen, Henrik Hasle, Linda Fogelstrand

Blood (2021) 138 (Supplement 1): 3457.

https://doi.org/10.1182/blood-2021-153411

Published: 2021

Journal Articles

Molecular MRD status and outcome after transplantation in NPM1 -mutated AML

Blood (2020) 135 (9): 680–688.

https://doi.org/10.1182/blood.2019002959

Published: 2020

Includes: Supplemental data

Journal Articles

Patient-Tailored Deep Sequencing of Peripheral Blood Enables Early Detection of Relapse in Childhood Acute Myeloid Leukemia

Kristian Løvvik Juul-Dam, MD, Erik Delsing Malmberg, Anna Rehammar, Erik Kristiansson, Jonas Abrahamsson, Anni Aggerholm, Marta Maria Dirdal, Kirsi Jahnukainen, Birgitte Lausen, Hans Beier Ommen, Henrik Hasle, Linda Fogelstrand

Blood (2019) 134 (Supplement_1): 1456.

https://doi.org/10.1182/blood-2019-124970

Published: 2019

Journal Articles

Measurable Residual Disease Assessment By qPCR in Peripheral Blood Is an Informative Tool for Disease Surveillance in Childhood Acute Myeloid Leukemia

Kristian Juul-Dam, MD, Hans Beier Ommen, Charlotte Guldborg Nyvold, Christiane Walter, Helen Vålerhaugen, Veli Kairisto, Jonas Abrahamsson, Sofie Johansson Alm, Kirsi Jahnukainen, Birgitte Lausen, Dirk Reinhardt, Bernward Zeller, Nils Von Neuhoff, Linda Fogelstrand, MD PhD, Henrik Hasle, MD

Blood (2018) 132 (Supplement 1): 2754.

https://doi.org/10.1182/blood-2018-99-119642

Published: 2018

Journal Articles

Post-Therapy Measurable Residual Disease Monitoring in Peripheral Blood Using Overexpressed Genes in Childhood Acute Myeloid Leukemia

Anne-Sofie Skou, MD, Kristian Juul-Dam, MD, Maria Hansen, PhD MSc, Anni Aggerholm, MSc, PhD, Birgitte Lausen, MD PhD, Charlotte Guldborg Nyvold, Hans Beier Ommen, MD PhD, Henrik Hasle, MD

Blood (2018) 132 (Supplement 1): 1480.

https://doi.org/10.1182/blood-2018-99-110014

Published: 2018

Journal Articles

Clonal Progression during First Course of Chemotherapy in Acute Myeloid Leukemia Suboptimal Responders Heralds Reinduction Failure and Early Death

Anita Tranberg Simonsen, BSc, MSc, Manja Meggendorfer, PhD, Sarah Koch, Annette Fasan, PhD, Wolfgang Kern, MD, Line Nederby, MSc, PhD, Peter Hokland, MD, Hans Beier Ommen, MD PhD

Blood (2017) 130 (Supplement 1): 1418.

https://doi.org/10.1182/blood.V130.Suppl_1.1418.1418

Published: 2017

Journal Articles

Relapse Kinetics in Acute Myeloid Leukemis Cases Encompassing More Than One Common Mutation: Towards a Unified Model

Hans Beier Ommen, MD PhD, Maria Hansen, MSc, PhD, Charlotte Guldborg Nyvold, MSc, PhD, Peter Hokland, MD DMSc

Blood (2014) 124 (21): 1055.

https://doi.org/10.1182/blood.V124.21.1055.1055

Published: 2014

Journal Articles

Cell Sorting Enables iFISH Detection Of Low BCR-ABL Producing Stem Cells In CML Patients Beyond Deep Molecular Remission

Peter Buur van Kooten Niekerk, MD, Charlotte Christie Petersen, MSc PhD, Charlotte Guldborg Nyvold, MSc, PhD, Hans Beier Ommen, MD, PhD, Anne Stidsholt Roug, MD, PhD, Line Nederby, MSc, PhD, Peter Hokland, MD, DMSC, Eigil Kjeldsen

Blood (2013) 122 (21): 1501.

https://doi.org/10.1182/blood.V122.21.1501.1501

Published: 2013

Journal Articles

Chronic Myeloid Leukemia Presenting with Isolated Thrombocythemia: A Case Revealing Its Stem Cell Biology

Peter Buur van Kooten Niekerk, MD, Anne Stidsholt Roug, MD, PhD, Line Nederby, MSc, PhD, Charlotte Christie Petersen, MSc, Hans Beier Ommen, MD, PhD, Eigil Kjeldsen, MD, Knud Bendix, Charlotte Guldborg Nyvold, MSc, PhD, Peter Hokland, MD, DMSC

Blood (2012) 120 (21): 4427.

https://doi.org/10.1182/blood.V120.21.4427.4427

Published: 2012

Journal Articles

Response: high ERG gene expression is an unfavorable prognostic marker in pediatric acute myeloid leukemia

Anna Staffas, Meena Kanduri, Randi Hovland, Richard Rosenquist, Hans Beier Ommen, Jonas Abrahamsson, Erik Forestier, Kirsi Jahnukainen, Ólafur G. Jónsson, Bernward Zeller, Josefine Palle, Gudmar Lönnerholm, Henrik Hasle, Hans Ehrencrona, Lars Palmqvist

Blood (2012) 119 (4): 1087–1088.

https://doi.org/10.1182/blood-2011-12-393355

Published: 2012

Journal Articles

Presence of FLT3 -ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia

Blood (2011) 118 (22): 5905–5913.

https://doi.org/10.1182/blood-2011-05-353185

Published: 2011

Includes: Supplemental data

Journal Articles

Mathematical Modeling and Comparisons of Relapse Patterns in AML with 11q23/ MLL translocations and Normal Karyotype AML with MLL -PTD

Hans Beier Ommen, MD, PhD, Peter Hokland, MD, DMSC, Torsten Haferlach, MD, Tamara Alpermann, Claudia Haferlach, MD, Wolfgang Kern, MD, Susanne Schnittger, PhD

Blood (2011) 118 (21): 750.

https://doi.org/10.1182/blood.V118.21.750.750

Published: 2011

Journal Articles

Sensitivity of MRD Detection in AML: qPCR Vs. MFC - a Plethora to Choose From, but Which Is Best?

Anne Stidsholt Roug, MD, Hanne Oestergaard Larsen, PhD, MSc,, Hans Beier Ommen, MD, PhD, Peter Hokland, MD, DMSC

Blood (2011) 118 (21): 1447.

https://doi.org/10.1182/blood.V118.21.1447.1447

Published: 2011

Journal Articles

Towards individualized follow-up in adult acute myeloid leukemia in remission

Peter Hokland, Hans Beier Ommen

Blood (2011) 117 (9): 2577–2584.

https://doi.org/10.1182/blood-2010-09-303685

Published: 2011

Journal Articles

Strikingly different molecular relapse kinetics in NPM1c , PML-RARA , RUNX1-RUNX1T1 , and CBFB-MYH11 acute myeloid leukemias

Hans Beier Ommen, Susanne Schnittger, Jelena V. Jovanovic, Ingrid Beier Ommen, Henrik Hasle, Mette Østergaard, David Grimwade, Peter Hokland

Blood (2010) 115 (2): 198–205.

https://doi.org/10.1182/blood-2009-04-212530

Published: 2010

Includes: Supplemental data

Journal Articles

Genetic and Epigenetic Events in Childhood AML - Similarities and Differences with Adult AML.

Caroline Juhl-Christensen, MD, PhD, Hans Beier Ommen, MD, PhD, Anni Aggerholm, PhD, Birgitte Lausen, MD, PhD, Eigil Kjeldsen, MD, Henrik Hasle, MD, PhD, Peter Hokland, MD, DMSc

Blood (2009) 114 (22): 2396.

https://doi.org/10.1182/blood.V114.22.2396.2396

Published: 2009

Journal Articles

Mathematical Modeling of Molecular Relapse Kinetics in NPM1c+, PML-Rara+, RUNX1-RUN1T1+, and CBFB-MYH11+ Acute Myeloid Leukemias

Hans Beier Ommen, Susanne Schnittger, Jelena V Jovanovic, Ingrid Beier Ommen, Henrik Hasle, Mette Oestergaard, David Grimwade, Peter Hokland

Blood (2008) 112 (11): 2525.

https://doi.org/10.1182/blood.V112.11.2525.2525

Published: 2008

Journal Articles

Expression Patterns of Hoxa4 and Meis1 Genes Are Regulated by Promoter Hypermethylation and When Combined Predict Survival in AML.

Lykke Christina Grubach, MSc, Mike Zangenberg, Hans Beier Ommen, M.D., Anni Aggerholm, Peter Hokland, M.D.

Blood (2008) 112 (11): 1204.

https://doi.org/10.1182/blood.V112.11.1204.1204

Published: 2008

NARROW

Molecular, clinical, and therapeutic determinants of outcome in NPM1 -mutated AML

Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission

Patient-Tailored Measurable Residual Disease Monitoring in Peripheral Blood Using Deep Sequencing and Droplet Digital PCR for Early Detection of Relapse in Childhood Acute Myeloid Leukemia: A NOPHO-DBH Collaborative Study

Molecular MRD status and outcome after transplantation in NPM1 -mutated AML

Patient-Tailored Deep Sequencing of Peripheral Blood Enables Early Detection of Relapse in Childhood Acute Myeloid Leukemia

Measurable Residual Disease Assessment By qPCR in Peripheral Blood Is an Informative Tool for Disease Surveillance in Childhood Acute Myeloid Leukemia

Post-Therapy Measurable Residual Disease Monitoring in Peripheral Blood Using Overexpressed Genes in Childhood Acute Myeloid Leukemia

Clonal Progression during First Course of Chemotherapy in Acute Myeloid Leukemia Suboptimal Responders Heralds Reinduction Failure and Early Death

Relapse Kinetics in Acute Myeloid Leukemis Cases Encompassing More Than One Common Mutation: Towards a Unified Model

Cell Sorting Enables iFISH Detection Of Low BCR-ABL Producing Stem Cells In CML Patients Beyond Deep Molecular Remission

Chronic Myeloid Leukemia Presenting with Isolated Thrombocythemia: A Case Revealing Its Stem Cell Biology

Response: high ERG gene expression is an unfavorable prognostic marker in pediatric acute myeloid leukemia

Presence of FLT3 -ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia

Mathematical Modeling and Comparisons of Relapse Patterns in AML with 11q23/ MLL translocations and Normal Karyotype AML with MLL -PTD

Sensitivity of MRD Detection in AML: qPCR Vs. MFC - a Plethora to Choose From, but Which Is Best?

Towards individualized follow-up in adult acute myeloid leukemia in remission

Strikingly different molecular relapse kinetics in NPM1c , PML-RARA , RUNX1-RUNX1T1 , and CBFB-MYH11 acute myeloid leukemias

Genetic and Epigenetic Events in Childhood AML - Similarities and Differences with Adult AML.

Mathematical Modeling of Molecular Relapse Kinetics in NPM1c+, PML-Rara+, RUNX1-RUN1T1+, and CBFB-MYH11+ Acute Myeloid Leukemias

Expression Patterns of Hoxa4 and Meis1 Genes Are Regulated by Promoter Hypermethylation and When Combined Predict Survival in AML.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only